Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

Let NVR Build Your Portfolio; KB and Toll Brothers Should Stay Home

By Peter Cohan, InvestorPlace Writer
NVR is thriving in a terrible industry, and its shares are cheap if it can meet its 2012 EPS target.

Buffett’s Golden Rule: 10 Stocks Trading for Less Than 10% Above Book Value

By Jamie Dlugosch, InvestorPlace Writer
During Berkshire's buyback announcement, Warren Buffett divulged his single most important secret for investing. Here are 10 stocks that fit his golden rule.

Coach is Most Clutch Among Luxury Leaders

By Peter Cohan, InvestorPlace Writer
Coach, Tiffany and Ralph Lauren are all profitable luxury companies, but COH's profit margin and relative value make it stand out.

Oil Plays: Why Drill When You Can Integrate?

By Peter Cohan, InvestorPlace Writer
Chevron is up while offshore drillers like Transocean and Diamond Offshore are down -- it all comes down to how they make their money.

5 Great Long-Term Growth Stocks

By Neil George
These "Long Hauler" stocks might not always be exciting, but they'll truck along to the tune of solid gains.

Mattel vs. Hasbro: Who’s the Star of This Season’s Toy Story?

By Susan J. Aluise, Aviation, Auto & Transportation Writer
Slumping economy or not, parents tend to open up the wallet during the holidays to buy toys. So, which toy giant is poised to fare better?

Microsoft Trumps Software Stocks Oracle, Salesforce.com

By Peter Cohan, InvestorPlace Writer
Oracle and Salesgrowth.com are a pair of differing feel-good stories, but despite slower growth, Microsoft still is the market leader -- and its stock is cheap.

Cablevision: The Company We Love to Hate

By Lawrence Meyers, InvestorPlace Contributor
Despite competitive pressures, bad press and management dramas, Cablevision's stock is a buy for many investors.

9 Oil and Energy Stocks to Power Your Portfolio

By Louis Navellier, Editor, Growth Investor
Although the energy sector hasn’t been booming, this still is a good buying opportunity for investors looking for oil & energy stocks.

6 Big-Name Blue Chips Rated ‘Strong Buy’

By Louis Navellier, Editor, Growth Investor
In this volatile market, blue-chip stocks are some of the only places investors can turn to. The following seven big large-cap stocks still are standing tall.

Carnival Shares — 3 Pros, 3 Cons

By Tom Taulli, InvestorPlace Contributor
Carnival Cruise Lines has shown it knows how to navigate challenges.

Auto Parts Stocks: 3 To Drive, 3 To Park

By Susan J. Aluise, Aviation, Auto & Transportation Writer
The rusting economy is making auto-repair stocks look good, but you have to weed through the scrap heap to find the right parts.

AutoZone Shares — 3 Pros, 3 Cons

By Tom Taulli, InvestorPlace Contributor
AutoZone didn't pop after earnings, but its sheer scale -- and its room to grow -- still make it an ideal long-term prospect.

5 Reasons UPS Is Poised to Win the Holiday Shipping Race

By Susan J. Aluise, Aviation, Auto & Transportation Writer
With its solid growth strategy and strong fundamentals, UPS enters the holiday season poised to deliver.

Berkshire Hathaway — A Big-Time Buy

By Lawrence Meyers, InvestorPlace Contributor
Diversified, with solid growth prospects, Berkshire Hathaway offers investors a lot to like.

3 Stocks Offering Value to Customers

By Jamie Dlugosch, InvestorPlace Writer
In a tumultuous economy, the lowest price on the totem pole usually wins. These three stocks provide consumers precisely that.

After Apple … the 3 Next-Best Blue-Chips

By Jeff Reeves
Many investors agree that AAPL is simply the best stock out there, but these three companies are close seconds.

3 Stocks Keeping Up With a Rapidly Changing World

By Jeff Reeves
You can rely on these companies to evolve and lead the market a decade from now. Check out these three buy-and-hold picks.

Give Bristol-Myers the Benefit Over Merck

By Peter Cohan, InvestorPlace Writer
Bristol-Myers’ robust new drug portfolio could make it an acquisition target -- and an investing target for you -- but neither stock is a bargain.
Load More Articles